Comparative sensitivity of commercially available aPTT reagents to mulga snake (Pseudechis australis) venom

SummaryThis study aimed to determine the relative sensitivity of activated partial thromboplastin time (aPTT) reagents to the anticoagulant effects of phospholipases in mulga snake (Pseu-s) venom. Twenty-one haematology laboratories participating in the Royal College of Pathologists of Australasia Quality Assurance Programs were sent human plasma samples spiked with mulga venom (n = 25 total results). Results for 17 patients with mulga snake envenoming were available through the Australian Snakebite Project. Only 12 of 25 venom spiked samples returned an abnormally prolonged aPTT Tests performed with Dade Actin FS (n = 7) did not identify any of the spiked samples as abnormal. Although clotting times were significantly prolonged using the lupus anticoagulant sensitive Actin FSL (n = 5, p = 0.043), only one was reported as abnormal. Only laboratories using TriniCLOTaPTTS (n = 6), Hemo-sIL APTT SP (n = 2) and Stago PTT-A (n = 1) consistently recorded the spiked sample as being above the upper normal reference interval. Abnormally prolonged aPTTs were recorded for four of eight patients whose tests were performed with Actin FSL, five of eight patients with TriniCLOTaPTT HS, and three of three patients using TriniCLOT aPTT S. We conclude that some reagents used for routine aPTT testing are relatively insensitive to the anticoagulant effects of mulga snake venom. Tests performed with these reagents should be interpreted with caution.